Together, our results demonstrate that co-inhibition of MDM2 (by nutlin-3) and MDMX (by NSC) has a profound inhibitory effect on cell growth of the wild-type p53 containing prostate cancer cells. The gene discussed is MDM2; the disease is prostate cancer.